Clinical Experience With a Unique Multimodal Skin Brightener for Facial Hyperpigmentation

March 2013 | Volume 12 | Issue 3 | Department | 13 | Copyright © March 2013


The Future is Now With SkinMedica’s Lytera™

The gold standard for the treatment of abnormal melanin accumulation has long been 4% hydroquinone, but, given the proliferating safety concerns posed by hydroquinone, the search for novel skin brighteners has been ongoing. Several studies have demonstrated that the future for skin brighteners is now, because of the skin brightening efficacy of SkinMedica’s Lytera™, a hydroquinone-free skin-brightening complex. Lytera includes a series of formulations that utilize a multi-modal treatment approach, and it is as effective as hydroquinone over the course of 24 weeks for the treatment of facial hyperpigmentation without the concomitant toxicities of the latter.